Literature DB >> 32503808

The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype.

Niels Vandamme1, Geertrui Denecker2, Kenneth Bruneel2, Gillian Blancke2, Özden Akay3, Joachim Taminau2, Jordy De Coninck4, Eva De Smedt2, Nicolas Skrypek2, Wouter Van Loocke5, Jasper Wouters6, David Nittner7, Corinna Köhler8, Douglas S Darling9, Phil F Cheng10, Marieke I G Raaijmakers11, Mitchell P Levesque12, Udupi Girish Mallya13, Mairin Rafferty14, Balazs Balint14, William M Gallagher15, Lieve Brochez16, Danny Huylebroeck17, Jody J Haigh18, Vanessa Andries2, Florian Rambow19, Pieter Van Vlierberghe20, Steven Goossens21, Joost J van den Oord22, Jean-Christophe Marine19, Geert Berx23.   

Abstract

EMT-inducing transcription factors (TF) are well known for their ability to induce mesenchymal states associated with increased migratory and invasive properties. Unexpectedly, nuclear expression of the EMT-TF ZEB2 in human primary melanoma has been shown to correlate with reduced invasion. We report here that ZEB2 is required for outgrowth for primary melanomas and metastases at secondary sites. Ablation of Zeb2 hampered outgrowth of primary melanomas in vivo, whereas ectopic expression enhanced proliferation and growth at both primary and secondary sites. Gain of Zeb2 expression in pulmonary-residing melanoma cells promoted the development of macroscopic lesions. In vivo fate mapping made clear that melanoma cells undergo a conversion in state where ZEB2 expression is replaced by ZEB1 expression associated with gain of an invasive phenotype. These findings suggest that reversible switching of the ZEB2/ZEB1 ratio enhances melanoma metastatic dissemination.
Copyright ©2020, American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32503808     DOI: 10.1158/0008-5472.CAN-19-2373

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

2.  Gene expression profile of epithelial-mesenchymal transition in tumours of patients with nonsmall cell lung cancer: the influence of COPD.

Authors:  Yingchen Xia; Jianhua Zha; Víctor Curull; Albert Sánchez-Font; Maria Guitart; Alberto Rodríguez-Fuster; Rafael Aguiló; Esther Barreiro
Journal:  ERJ Open Res       Date:  2022-07-18

Review 3.  MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance.

Authors:  Maria Chiara Gelmi; Laurien E Houtzagers; Thomas Strub; Imène Krossa; Martine J Jager
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

Review 4.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

Review 5.  Rethinking the biology of metastatic melanoma: a holistic approach.

Authors:  Hendrik Hld Vandyck; Lisa M Hillen; Francesca M Bosisio; Joost van den Oord; Axel Zur Hausen; Véronique Winnepenninckx
Journal:  Cancer Metastasis Rev       Date:  2021-04-19       Impact factor: 9.264

Review 6.  Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy-An Integrated View into Other Neoplasms and Chemokine Networks.

Authors:  Anca Filimon; Iulia A Preda; Adina F Boloca; Gabriela Negroiu
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

7.  Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival.

Authors:  Alberto Vázquez-Naharro; José Bustos-Tauler; Alfredo Floristán; Lourdes Yuste; Sara S Oltra; Antònia Vinyals; Gema Moreno-Bueno; Àngels Fabra; Francisco Portillo; Amparo Cano; Patricia G Santamaría
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

8.  Identification of gastric cancer subtypes based on pathway clustering.

Authors:  Lin Li; Xiaosheng Wang
Journal:  NPJ Precis Oncol       Date:  2021-06-02

9.  Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets.

Authors:  Anais Prouteau; Stephanie Mottier; Aline Primot; Edouard Cadieu; Laura Bachelot; Nadine Botherel; Florian Cabillic; Armel Houel; Laurence Cornevin; Camille Kergal; Sébastien Corre; Jérôme Abadie; Christophe Hitte; David Gilot; Kerstin Lindblad-Toh; Catherine André; Thomas Derrien; Benoit Hedan
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639

Review 10.  ZEB2, the Mowat-Wilson Syndrome Transcription Factor: Confirmations, Novel Functions, and Continuing Surprises.

Authors:  Judith C Birkhoff; Danny Huylebroeck; Andrea Conidi
Journal:  Genes (Basel)       Date:  2021-07-03       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.